Skip to main content

Table 2 Association between Lp(a) and laboratory indices in all participants, male group and female group, respectively

From: Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients

 

Lp(a)

  

All

Male

Female

r

P value

r

P value

r

P value

Age (years)

0.041

0.409

0.057

0.457

0.058

0.373

BMI (kg/m2)

−0.019

0.697

0.076

0.322

−0.052

0.421

TC (mmol/L)

0.081

0.347

0.095

0.213

0.176

0.006*

TG (mmol/L)

−0.142

0.004*

−0.178

0.020*

−0.090

0.168

HDL-C (mmol/L)

−0.016

0.855

0.175

0.022*

0.060

0.360

LDL-C (mmol/L)

0.132

0.123

0.183

0.016*

0.228

< 0.001**

FBG (mmol/L)

−0.039

0.443

−0.005

0.953

−0.027

0.688

FINS (uIU/ml)

−0.069

0.174

0.073

0.349

−0.058

0.383

GH (ng/ml)

0.139

0.006*

0.223

0.004*

0.054

0.408

TES (nmol/L)

−0.190

< 0.001**

−0.206

0.007*

−0.201

0.002*

HFSH (mIU/ml)

−0.021

0.669

−0.085

0.269

−0.008

0.902

LH (mIU/ml)

0.016

0.743

0.009

0.910

−0.015

0.815

PRL (mIU/ml)

0.047

0.345

0.019

0.804

0.040

0.538

E2 (pmol/L)

0.063

0.210

0.175

0.025*

−0.021

0.749

HOMA-IR

−0.067

0.188

−0.046

0.557

−0.055

0.415

  1. Lp(a) lipoprotein (a); BMI body mass index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FBG fasting blood glucose, FINS fasting insulin, GH growth hormone, TES testosterone, HFSH follicle-stimulating hormone, LH luteinizing hormone, PRL prolactin, E2 estradiol, HOMA-IR homeostasis model assessment of insulin resistance. * P < 0.05, ** P < 0.001